Adverse Events Of The Thyroid Peroxidase Inhibitor Methimazole In The Treatment Of Hyperthyroidism: A Comprehensive Analysis From The First Quarter Of 2004 To The First Quarter Of 2025

    October 2025 in “ Frontiers in Endocrinology
    Yixin Sun, Shuai Wang, Xu Zhou
    Studysummary This study confirmed that methimazole use is associated with agranulocytosis, pyrexia, exposure during pregnancy, and hyperthyroidism, while also identifying new safety signals like premature birth and septic shock that require further investigation.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →